Hyperphosphorylated Serine 262 is observed frequently in the AD brain and most highly inhibits Tau’s ability to bind to microtubules (Fischer et al., 2009; Haj-Yahya et al., 2020). This evidence concerns the gene MAPT and Alzheimer disease.